NitroMed BiDil Recommended For Heart Failure In Self-Identified African-Americans

Indication to treat heart failure in the general population is discussed, but rejected, by FDA’s Cardiovascular & Renal Drugs Advisory Committee. Despite mortality benefit seen in A-HeFT, some committee members call strength of evidence a “close call.”

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet